{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:30:21Z","timestamp":1788777021408,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":67,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031598142","type":"print"},{"value":"9783031598159","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-59815-9_4","type":"book-chapter","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:01:55Z","timestamp":1723154515000},"page":"33-42","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical Features of Cytokine Storm Syndrome"],"prefix":"10.1007","author":[{"given":"Masaki","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00018-011-0835-y","volume":"69","author":"E Sieni","year":"2012","unstructured":"Sieni E, Cetica V, Mastrodicasa E, Pende D, Moretta L, Griffiths G, et al. Familial hemophagocytic lymphohistiocytosis: a model for understanding the human machinery of cellular cytotoxicity. Cell Mol Life Sci. 2012;69:29\u201340.","journal-title":"Cell Mol Life Sci"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","volume":"78","author":"JI Henter","year":"1991","unstructured":"Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hyper-cytokinemia in familial hemophagocytic lymphohistiocytosis. Blood. 1991;78:2918\u201322.","journal-title":"Blood"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00134-008-1111-y","volume":"34","author":"C Cre\u2019put","year":"2008","unstructured":"Cre\u2019put C, Galicier L, Buyse S, Azoulay E. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med. 2008;34:1177\u201387.","journal-title":"Intensive Care Med"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.30105","volume":"63","author":"HJ Lachmann","year":"2011","unstructured":"Lachmann HJ, Quartier P, So A, Hawkins PN. The emerging role of interleukin- 1b in autoinflammatory diseases. Arthritis Rheum. 2011;63:314\u201324.","journal-title":"Arthritis Rheum"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","volume":"4","author":"CA Dinarello","year":"2013","unstructured":"Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013;4:289.","journal-title":"Front Immunol"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0002-9270(00)02425-4","volume":"96","author":"C De Kerguenec","year":"2001","unstructured":"De Kerguenec C, Hillaire S, Molini\u00e9 V, Gardin C, Degott C, Erlinger S, et al. Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol. 2001;96:852\u20137.","journal-title":"Am J Gastroenterol"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2014.05.005","volume":"26","author":"A Avau","year":"2014","unstructured":"Avau A, Put K, Wouters CH, Matthys P. Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis. Cytokine Growth Factor Rev. 2014;26:35\u201345.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00431-006-0258-1","volume":"166","author":"GE Janka","year":"2007","unstructured":"Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr. 2007;166:95\u2013109.","journal-title":"Eur J Pediatr"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cytogfr.2014.10.001","volume":"26","author":"E Brisse","year":"2015","unstructured":"Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders. Cytokine Growth Factor Rev. 2015;26:263\u201380.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF00443367","volume":"140","author":"GE Janka","year":"1983","unstructured":"Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr. 1983;140:221\u201330.","journal-title":"Eur J Pediatr"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1182\/blood.V89.3.794","volume":"89","author":"E Haddad","year":"1997","unstructured":"Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood. 1997;89:794\u2013800.","journal-title":"Blood"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pediatrneurol.2013.10.014","volume":"50","author":"A Jovanovic","year":"2014","unstructured":"Jovanovic A, Kuzmanovic M, Kravljanac R, Micic D, Jovic M, Gazikalovic S, Pasic S. Central nervous system involvement in hemophagocytic lymphohistiocytosis: a single-center experience. Pediatr Neurol. 2014;50:233\u20137.","journal-title":"Pediatr Neurol"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Dav\u00ec S, Horne A, Demirkaya E, Bovis F, Li C, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rhematol. 2014;66:3160\u20139.","journal-title":"Arthritis Rhematol"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00296-016-3545-9","volume":"36","author":"S Ayta\u00e7","year":"2016","unstructured":"Ayta\u00e7 S, Batu ED, \u00dcnal \u015e, Bilginer Y, \u00c7etin M, Tuncer M, G\u00fcmr\u00fck F, \u00d6zen S. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Rheumatol Int. 2016;36:1421\u20139.","journal-title":"Rheumatol Int"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.autrev.2017.05.010","volume":"16","author":"PE Gavand","year":"2017","unstructured":"Gavand PE, Serio I, Arnaud L, Costedoat-Chalumeau N, Carvelli J, Dossier A, et al. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients. Autoimmun Rev. 2017;16:743\u20139.","journal-title":"Autoimmun Rev"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/pbc.24980","volume":"61","author":"K Kogawa","year":"2014","unstructured":"Kogawa K, Sato H, Asano T, Ohga S, Kudo K, Morimoto A, et al. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Pediatr Blood Cancer. 2014;61:1257\u201362.","journal-title":"Pediatr Blood Cancer"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005792-198811000-00002","volume":"67","author":"AP Reiner","year":"1988","unstructured":"Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore). 1988;67:369\u201388.","journal-title":"Medicine (Baltimore)"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1600-0609.1995.tb00264.x","volume":"55","author":"K Shirono","year":"1995","unstructured":"Shirono K, Tsuda H. Virus-associated haemophagocytic syndrome in previously healthy adults. Eur J Haematol. 1995;55:240\u20134.","journal-title":"Eur J Haematol"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/hon.960","volume":"29","author":"M Shabbir","year":"2011","unstructured":"Shabbir M, Lucas J, Lazarchick J, Shirai K. Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol Oncol. 2011;29:100\u20136.","journal-title":"Hematol Oncol"},{"key":"4_CR20","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. 2007;34:1133\u20138.","journal-title":"J Rheumatol"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/01.shk.0000209520.82377.41","volume":"25","author":"K Kuwata","year":"2006","unstructured":"Kuwata K, Yamada S, Kinuwaki E, Naito M, Mitsuya H. Peripheral hemophagocytosis: an early indicator of advanced systemic inflammatory response syndrome\/hemophagocytic syndrome. Shock. 2006;25:344\u201350.","journal-title":"Shock"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/bmt.2011.95","volume":"47","author":"N Imahashi","year":"2012","unstructured":"Imahashi N, Inamoto Y, Ito M, Koyama D, Goto T, Onodera K, et al. Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT. Bone Marrow Transplant. 2012;47:387\u201394.","journal-title":"Bone Marrow Transplant"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2016.02.008","volume":"80","author":"Y Tasaki","year":"2016","unstructured":"Tasaki Y, Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Wada T, et al. Disruption of vascular endothelial homeostasis in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the dynamic roles of angiopoietin \u22121 and \u22122. Cytokine. 2016;80:1\u20136.","journal-title":"Cytokine"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s13054-015-1075-6","volume":"19","author":"Y Fang","year":"2015","unstructured":"Fang Y, Li C, Shao R, Yu H, Zhang Q, Zhao L. Prognostic significance of the angiopoietin-2\/angiopoietin-1 and angiopoietin-1\/Tie-2 ratios for early sepsis in an emergency department. Crit Care. 2015;19:367.","journal-title":"Crit Care"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0022-3476(74)80287-8","volume":"85","author":"PD McClure","year":"1974","unstructured":"McClure PD, Strachan P, Saunders EF. Hypofibrinogenemia and thrombocytopenia in familial hemophagocytic reticulosis. J Pediatr. 1974;85:67\u201370.","journal-title":"J Pediatr"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","volume":"63","author":"GE Janka","year":"2012","unstructured":"Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012;63:233\u201346.","journal-title":"Annu Rev Med"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/acr2.11048","volume":"1","author":"EMA Eloseily","year":"2019","unstructured":"Eloseily EMA, Minoia F, Crayne CB, Beukelman T, Ravelli A, Cron RQ. Ferritin to erythrocyte sedimentation rate ratio: simple measure to identify macrophage activation syndrome in systemic juvenile idiopathic arthritis. ACR Open Rheumatol. 2019;1:345\u20139.","journal-title":"ACR Open Rheumatol"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3899\/jrheum.100833","volume":"8","author":"M Gorelik","year":"2011","unstructured":"Gorelik M, Torok KS, Kietz DA, Hirsch R. Hypocomplementemia associated with macrophage activation syndrome in systemic juvenile idiopathic arthritis and adult onset still's disease: 3 cases. J Rheumatol. 2011;8:396\u20137.","journal-title":"J Rheumatol"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1086\/516086","volume":"25","author":"F St\u00e9phan","year":"1997","unstructured":"St\u00e9phan F, Thioli\u00e8re B, Verdy E, Tulliez M. Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock. Clin Infect Dis. 1997;25:1159\u201364.","journal-title":"Clin Infect Dis"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/10428190701713630","volume":"49","author":"H Tong","year":"2008","unstructured":"Tong H, Ren Y, Liu H, Xiao F, Mai W, Meng H, et al. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome. Leuk Lymphoma. 2008;49:81\u20137.","journal-title":"Leuk Lymphoma"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jmii.2011.01.027","volume":"44","author":"YT Tseng","year":"2011","unstructured":"Tseng YT, Sheng WH, Lin BH, Lin CW, Wang JT, Chen YC, et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011;44:191\u201319.","journal-title":"J Microbiol Immunol Infect"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00277-007-0278-6","volume":"86","author":"AR Han","year":"2007","unstructured":"Han AR, Lee HR, Park BB, Hwang IG, Park S, Lee SC, et al. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. Ann Hematol. 2007;86:493\u20138.","journal-title":"Ann Hematol"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1001\/archderm.138.9.1208","volume":"138","author":"DS Morrell","year":"2002","unstructured":"Morrell DS, Pepping MA, Scott JP, Esterly NB, Drolet BA. Cutaneous manifestations of hemophagocytic lymphohistiocytosis. Arch Dermatol. 2002;138:1208\u201312.","journal-title":"Arch Dermatol"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/DAD.0b013e3181b2a50f","volume":"32","author":"WJ Lee","year":"2010","unstructured":"Lee WJ, Lee DW, Kim CH, Won CH, Chang SE, Lee MW, et al. Dermatopathic lymphadenitis with generalized erythroderma in a patient with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Am J Dermatopathol. 2010;32:357\u201361.","journal-title":"Am J Dermatopathol"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/01.TP.0000107285.86939.37","volume":"77","author":"A Karras","year":"2004","unstructured":"Karras A, Thervet E, Legendre C, The Groupe Cooperatif de transplantation d\u2019Ile de France. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature. Transplantation. 2004;77:238\u201343.","journal-title":"Transplantation"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1651-2227.1994.tb13000.x","volume":"83","author":"H Ohta","year":"1994","unstructured":"Ohta H, Yumara-Yagi K, Sakata N, Inoue M, Kawa-Ha K. Capillary leak syndrome in patients with hemophagocytic lymphohistiocytosis. Acta Paediatr. 1994;83:1113\u20134.","journal-title":"Acta Paediatr"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/MPH.0b013e318257a4cb","volume":"34","author":"M Kuzmanovic","year":"2012","unstructured":"Kuzmanovic M, Pasic S, Prijic S, Jovanovic A, Kosutic J. Severe transient left ventricular pseudohypertrophy during treatment of hemophagocytic lymphohistiocytosis: a case report. J Pediatr Hematol Oncol. 2012;34:453\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12887-016-0718-3","volume":"16","author":"Y Kawamura","year":"2016","unstructured":"Kawamura Y, Miura H, Matsumoto Y, Uchida H, Kudo K, Hata T, et al. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications. BMC Pediatr. 2016;16:172.","journal-title":"BMC Pediatr"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.ajkd.2014.10.012","volume":"65","author":"F Aulagnon","year":"2015","unstructured":"Aulagnon F, Lapidus N, Canet E, Galicier L, Boutboul D, Peraldi MN, et al. Acute kidney injury in adults with hemophagocytic lymphohistiocytosis. Am J Kidney Dis. 2015;65:851\u20139.","journal-title":"Am J Kidney Dis"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/sj.ki.5000352","volume":"69","author":"O Thaunat","year":"2006","unstructured":"Thaunat O, Delahousse M, Fakhouri F, Martinez F, Stephan JL, No\u00ebl LH, et al. Nephrotic syndrome associated with hemophagocytic syndrome. Kidney Int. 2006;69:1892\u20138.","journal-title":"Kidney Int"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1681\/ASN.2014111090","volume":"26","author":"L Malaga-Dieguez","year":"2015","unstructured":"Malaga-Dieguez L, Ming W, Trachtman H. Direct reversible kidney injury in familial hemophagocytic lymphohistiocytosis type 3. J Am Soc Nephrol. 2015;26:1777\u201380.","journal-title":"J Am Soc Nephrol"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1007\/s00467-013-2583-8","volume":"28","author":"D Landau","year":"2013","unstructured":"Landau D, Gurevich E, Kapelushnik J, Tamary H, Shelef I, Lazar I. Association between childhood nephrotic syndromeand hemophagocytic lymphohistiocytosis. Pediatr Nephrol. 2013;28:2389\u201392.","journal-title":"Pediatr Nephrol"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jpeds.2021.04.004","volume":"235","author":"F Minoia","year":"2021","unstructured":"Minoia F, Tibaldi J, Muratore V, Gallizzi R, Bracaglia C, Arduini A, MAS\/sJIA Working Group of the Pediatric Rheumatology European Society (PReS). Thrombotic microangiopathy associated with macrophage activation syndrome: a multinational study of 23 patients. J Pediatr. 2021;235:196\u2013202.","journal-title":"J Pediatr"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/rheumatology\/ken342","volume":"47","author":"S Fukaya","year":"2008","unstructured":"Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008;47:1686\u201391.","journal-title":"Rheumatology (Oxford)"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1177\/0883073808319073","volume":"23","author":"A Gurgey","year":"2008","unstructured":"Gurgey A, Aytac S, Balta G, Oguz KK, Gumruk F. Central nervous system involvement in Turkish children with primary hemophagocytic lymphohistiocytosis. J Child Neurol. 2008;23:1293\u20139.","journal-title":"J Child Neurol"},{"key":"4_CR46","doi-asserted-by":"publisher","first-page":"E187","DOI":"10.1227\/01.NEU.0000146210.13318.E8","volume":"56","author":"J Shinoda","year":"2005","unstructured":"Shinoda J, Murase S, Takenaka K, Sakai N. Isolated central nervous system hemophagocytic lymphohistiocytosis: case report. Neurosurgery. 2005;56:E187\u201390.","journal-title":"Neurosurgery"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1177\/0883073811435237","volume":"27","author":"KW Chong","year":"2012","unstructured":"Chong KW, Lee JH, Choong CT, Paeds MM, Chan DW, Fortier MV, et al. Hemophagocytic lymphohistiocytosis with isolated central nervous system reactivation and optic nerve involvement. J Child Neurol. 2012;27:1336\u20139.","journal-title":"J Child Neurol"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5045\/br.2013.48.4.258","volume":"48","author":"G Lee","year":"2013","unstructured":"Lee G, Lee SE, Ryu KH, Yoo ES. Posterior reversible encephalopathy syndrome in pediatric patients undergoing treatment for hemophagocytic lymphohistiocytosis: clinical outcomes and putative risk factors. Blood Res. 2013;48:258\u201365.","journal-title":"Blood Res"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jpeds.2009.02.050","volume":"155","author":"N Suzuki","year":"2009","unstructured":"Suzuki N, Morimoto A, Ohga S, Kudo K, Ishida Y, Ishii E, HLH\/LCH Committee of the Japanese Society of Pediatric Hematology. Characteristics of hemophagocytic lymphohistiocytosis in neonates: a nationwide survey in Japan. J Pediatr. 2009;155:235\u20138.","journal-title":"J Pediatr"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1365-2141.1989.tb00302.x","volume":"73","author":"T Hanada","year":"1989","unstructured":"Hanada T, Ono I, Iinuma S, Nagai Y. Pure red cell aplasia in association with virus associated haemophagocytic syndrome (VAHS). Br J Haematol. 1989;73:570\u20131.","journal-title":"Br J Haematol"},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","volume":"105","author":"AD Billiau","year":"2005","unstructured":"Billiau AD, Roskams T, Van DammeLombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF alpha-producing macrophages. Blood. 2005;105:1648\u201351.","journal-title":"Blood"},{"key":"4_CR52","first-page":"1273","volume":"22","author":"JF Whiting","year":"1995","unstructured":"Whiting JF, Green RM, Rosenbluth AB, Gollan JL. Tumor necrosis factor alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology. 1995;22:1273\u20138.","journal-title":"Hepatology"},{"key":"4_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1018871920247","volume":"43","author":"ON Iso","year":"1998","unstructured":"Iso ON, Hashimoto N, Tanaka A, Sunaga S, Oka T, Kurokawa K, et al. Cytokine-induced hypoalbuminemia in a patient with hemophagocytic syndrome: direct in vitro evidence for the role of tumor necrosis factor-alpha. Dig Dis Sci. 1998;43:67\u201373.","journal-title":"Dig Dis Sci"},{"key":"4_CR54","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.20190669","volume":"216","author":"S Belkaya","year":"2019","unstructured":"Belkaya S, Michailidis E, Korol CB, Kabbani M, Cobat A, Bastard P, Lee YS, Hernandez N, Drutman S, de Jong YP, Vivier E, Bruneau J, B\u00e9ziat V, Boisson B, Lorenzo-Diaz L, Boucherit S, Sebagh M, Jacquemin E, Emile JF, Abel L, Rice CM, Jouanguy E, Casanova JL. Inherited IL-18BP deficiency in human fulminant viral hepatitis. J Exp Med. 2019;216:1777\u201390.","journal-title":"J Exp Med"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fimmu.2012.00239","volume":"3","author":"L Chiossone","year":"2012","unstructured":"Chiossone L, Audonnet S, Chetaille B, et al. Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein. Front Immunol. 2012;3:239.","journal-title":"Front Immunol"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1200\/JCO.1993.11.3.499","volume":"11","author":"J Weber","year":"1993","unstructured":"Weber J, Yang JC, Topalian SL, Parkinson DR, Schwartzentruber DS, Ettinghausen SE, et al. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol. 1993;11:499\u2013506.","journal-title":"J Clin Oncol"},{"key":"4_CR57","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.1993.03500140081040","volume":"269","author":"CA Dinarello","year":"1993","unstructured":"Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA J Am Med Assoc. 1993;269:1829\u201335.","journal-title":"JAMA J Am Med Assoc"},{"key":"4_CR58","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1651-2227.1991.tb11928.x","volume":"80","author":"JI Henter","year":"1991","unstructured":"Henter JI, Carlson LA, Soder O, Nilsson-Ehle P, Elinder G. Lipoprotein alterations and plasma lipoprotein lipase reduction in familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand. 1991;80:675\u201381.","journal-title":"Acta Paediatr Scand"},{"key":"4_CR59","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/1097-0142(19880515)61:10<2071::AID-CNCR2820611023>3.0.CO;2-6","volume":"61","author":"N Esumi","year":"1988","unstructured":"Esumi N, Ikushima S, Hibi S, Todo S, Imashuku S. High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer. 1988;61:2071\u20136.","journal-title":"Cancer"},{"key":"4_CR60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"4_CR61","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/1529-0131(200104)44:4<884::AID-ANR145>3.0.CO;2-4","volume":"44","author":"K Shibatomi","year":"2001","unstructured":"Shibatomi K, Ida H, Yamasaki S, Nakashima T, Origuchi T, Kawakami A, et al. A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases. Arthritis Rheum. 2001;44:884\u201392.","journal-title":"Arthritis Rheum"},{"key":"4_CR62","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/art.24750","volume":"60","author":"W de Jager","year":"2009","unstructured":"de Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ, et al. Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009;60:2782\u201393.","journal-title":"Arthritis Rheum"},{"key":"4_CR63","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/art.39295","volume":"67","author":"L Cifaldi","year":"2015","unstructured":"Cifaldi L, Prencipe G, Caiello I, Bracaglia C, Locatelli F, De Benedetti F, et al. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome. Arthritis Rhematol. 2015;67:3037\u201346.","journal-title":"Arthritis Rhematol"},{"key":"4_CR64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.20140964","volume":"212","author":"MR Jenkins","year":"2015","unstructured":"Jenkins MR, Rudd-Schmidt JA, Lopez JA, Ramsbottom KM, Mannering SI, Andrews DM, et al. Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212:307\u201317.","journal-title":"J Exp Med"},{"key":"4_CR65","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41423-019-0277-2","volume":"17","author":"M Anft","year":"2020","unstructured":"Anft M, Netter P, Urlaub D, Prager I, Schaffner S, Watzl C. NK cell detachment from target cells is regulated by successful cytotoxicity and influences cytokine production. Cell Mol Immunol. 2020;17:347\u201355.","journal-title":"Cell Mol Immunol"},{"key":"4_CR66","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","volume":"49","author":"M Shimizu","year":"2010","unstructured":"Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford). 2010;49:1645\u201353.","journal-title":"Rheumatology (Oxford)"},{"key":"4_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clim.2012.11.004","volume":"146","author":"M Shimizu","year":"2013","unstructured":"Shimizu M, Yokoyama T, Tokuhisa Y, Ishikawa S, Sakakibara Y, Ueno K, et al. Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome. Clin Immunol. 2013;146:73\u20136.","journal-title":"Clin Immunol"}],"container-title":["Advances in Experimental Medicine and Biology","Cytokine Storm Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-59815-9_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:02:40Z","timestamp":1723154560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-59815-9_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031598142","9783031598159"],"references-count":67,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-59815-9_4","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"9 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}